Novo Nordisk weighs diabetes drug's use in fatty liver disease

COPENHAGEN (Reuters) - Novo Nordisk is looking into recent clinical trial data that show its diabetes drug Victoza has potential as a treatment for fatty liver disease, a hot area for pharmaceutical development.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news